Research Analysts’ Updated EPS Estimates for December 23rd (ACRS, AMTX, APLT, AVXL, BWAY, CAE, CSAN, EL, ENGN, EVTL)

Research Analysts’ updated eps estimates for Monday, December 23rd:

Aclaris Therapeutics (NASDAQ:ACRS) was upgraded by analysts at HC Wainwright from a neutral rating to a buy rating. HC Wainwright currently has $20.00 target price on the stock.

Aemetis (NASDAQ:AMTX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $28.00 target price on the stock.

Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.

Anavex Life Sciences (NASDAQ:AVXL) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $46.00 price target on the stock.

BrainsWay (NASDAQ:BWAY) had its buy rating reissued by analysts at HC Wainwright. They currently have a $16.00 target price on the stock.

CAE (NYSE:CAE) (TSE:CAE) was upgraded by analysts at Desjardins from a hold rating to a buy rating.

Cosan (NYSE:CSAN) had its buy rating reissued by analysts at Citigroup Inc.. They currently have a $19.00 price target on the stock.

Estée Lauder Companies (NYSE:EL) had its buy rating reissued by analysts at DA Davidson. The firm currently has a $81.00 price target on the stock.

enGene (NASDAQ:ENGN) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $18.00 target price on the stock.

Vertical Aerospace (NYSE:EVTL) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a $16.00 price target on the stock.

GCM Grosvenor (NASDAQ:GCMG) was upgraded by analysts at Piper Sandler from a neutral rating to an overweight rating. They currently have $14.00 price target on the stock, up from their previous price target of $12.50.

Alphabet (NASDAQ:GOOGL) had its buy rating reiterated by analysts at Bank of America Co.. They currently have a $210.00 target price on the stock.

Huntington Bancshares (NASDAQ:HBAN) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $20.00 price target on the stock.

Honeywell International (NASDAQ:HON) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Innovative Industrial Properties (NYSE:IIPR) was downgraded by analysts at BTIG Research from a buy rating to a neutral rating.

Jasper Therapeutics (NASDAQ:JSPR) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $68.00 price target on the stock.

Kroger (NYSE:KR) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $70.00 price target on the stock.

Ligand Pharmaceuticals (NASDAQ:LGND) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $135.00 target price on the stock.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Mesoblast (NASDAQ:MESO) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating.

Merit Medical Systems (NASDAQ:MMSI) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $114.00 target price on the stock.

Vail Resorts (NYSE:MTN) had its equal weight rating reiterated by analysts at Morgan Stanley. They currently have a $197.00 target price on the stock.

Neurocrine Biosciences (NASDAQ:NBIX) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $160.00 price target on the stock.

Netlist (OTCMKTS:NLST) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Ollie’s Bargain Outlet (NASDAQ:OLLI) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $130.00 price target on the stock.

Puma Biotechnology (NASDAQ:PBYI) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $7.00 price target on the stock.

PotlatchDeltic (NASDAQ:PCH) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating. The firm currently has $45.00 target price on the stock.

REE Automotive (NASDAQ:REE) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $15.00 price target on the stock.

Rockwell Medical (NASDAQ:RMTI) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $7.00 target price on the stock.

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $69.00 price target on the stock.

Rhythm Pharmaceuticals (NASDAQ:RYTM) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $75.00 price target on the stock.

60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its neutral rating reiterated by analysts at HC Wainwright.

Tamboran Resources (NYSE:TBN) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $41.00 target price on the stock.

Vanda Pharmaceuticals (NASDAQ:VNDA) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $18.00 target price on the stock.

VYNE Therapeutics (NASDAQ:VYNE) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $5.75 target price on the stock.

Winnebago Industries (NYSE:WGO) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $70.00 target price on the stock.

Weyerhaeuser (NYSE:WY) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating. They currently have $32.00 target price on the stock.